| Zulema Salazar, RN | |
|
712 St. John St., Garden City, KS 67846 | |
| (620) 275-1766 | |
| (620) 275-4729 |
| Full Name | Zulema Salazar |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 712 St. John St., Garden City, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447668629 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 123636 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Zulema Salazar, RN 712 St. John St., Garden City, KS 67846 Ph: (620) 275-1766 | Zulema Salazar, RN 712 St. John St., Garden City, KS 67846 Ph: (620) 275-1766 |
News Archive
New preclinical data on velafermin (CG53135), CuraGen's Phase II clinical product being developed for the prevention of oral mucositis (OM), suggesting that velafermin may protect the gastrointestinal tract and decrease associated toxicity, including enteritis and diarrhea, following exposure to radiation.
Widespread use of pesticides and other agrochemicals can speed the transmission of the debilitating disease schistosomiasis, while also upsetting the ecological balances in aquatic environments that prevent infections, finds a new study led by researchers at the University of California, Berkeley.
CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its pre-Investigational New Drug meeting package for the proposed Phase 2 trial of CytoSen's adoptive NK cell therapy, CSTD002-NK, for the reduction of relapse in high risk acute myeloid leukemia or myelodysplastic syndrome in patients undergoing haploidentical hematopoietic stem cell transplantation.
The Wearable Technology Show – the world's biggest dedicated wearables event – opens its doors in London next Tuesday. With 110 exhibitors and nearly 200 speakers, the event has more than doubled in size since its launch last March and is already respected globally as the ultimate destination for everyone involved in wearables.
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2012.
› Verified 5 days ago
Lourdes Sofia Avinaz, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2222 | |
Mr. Jim Clasen, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2222 Fax: 620-272-2127 | |
Mrs. Joan Loryane Booker, ARNP,CDE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2323 Fax: 620-272-2387 | |
Tiffany Pruitt, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 712b Saint John St, Garden City, KS 67846 Phone: 620-275-1766 Fax: 275-275-4729 | |
Jennifer Ann Payne, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2630 | |
Roger Eugene Bradshaw, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 606 N Main St, Garden City, KS 67846 Phone: 620-272-6186 Fax: 620-275-7364 | |
Alexis D King, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 585 S Deer Trak, Garden City, KS 67846 Phone: 620-290-2466 Fax: 620-272-2489 |